KEGG   DRUG: Respiratory syncytial virus vaccine
Entry
D12607                      Drug                                   
Name
Respiratory syncytial virus vaccine;
Respiratory syncytial virus vaccine, adjuvanted;
Recombinant respiratory syncytial virus vaccine;
Arexvy (TN);
Abrysvo (TN);
mResvia (TN)
Product
Remark
Therapeutic category: 6313
ATC code: J07BX05
Product: D12607<JP/US>
Efficacy
Active immunization (RSV)
  Disease
Prevention of lower respiratory tract disease caused by respiratory syncytial virus [DS:H00401]
Comment
Arexvy (TN): Recombinant RSVPreF3 antigen
Abrysvo (TN): Recombinant RSV preF A and RSV preF B antigen
Target
RSV F protein [KO:K19261]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BX Other viral vaccines
     J07BX05 Respiratory syncytial virus vaccines
      D12607  Respiratory syncytial virus vaccine <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Respiratory Syncytial Virus
    Respiratory Syncytial Virus Vaccine (Recombinant [Adjuvanted])
     D12607  Respiratory syncytial virus vaccine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D12607  Respiratory syncytial virus vaccine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12607
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D12607
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12607
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12607
Other DBs
PubChem: 497621020
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system